AzTrials
AzTrials

Psychiatric DisorderPACTNCT05306717

Impact of the Preventive Emotions Management Questionnaire on the Rates of Isolation and Mechanical Restraint Measures in the Psychiatric Admission Unit

An observational study of Psychiatric Disorder, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This observational study assesses whether the use of the QPGE has an impact on the rates of isolation and mechanical restraint in adult psychiatric admission units. It is supplemented by a qualitative survey that will collect the experience of caregivers using the QPGE. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychiatric Disorder
What is being tested?
Questionnaire
How many people
416 participants
Where
1 siteFrance
Study dates
1 Apr 2022to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: People with psychiatric disorders and hospitalized in a sectoral admission unit receiving patients in care without consent

Who may be able to join

  • Have been hospitalized in psychiatric admission unit with an entry date between January 1, 2020 and December 31, 2020
  • Be at least 18 years old at the time of hospitalization
  • Master the French language in order to have benefited from the QPGE and the satisfaction questionnaire

Who cannot join

  • Being the subject of an isolation and/or restraint measure, decided in another unit before, during the transfer to the study places
  • To have objected to the use of data collected during hospitalization following the information in the welcome booklet

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Charles Perrens

    Bordeaux, Gironde, 33000

Other trials in France

About this study

This observational study assesses whether the use of the QPGE has an impact on the rates of isolation and mechanical restraint in adult psychiatric admission units. It is supplemented by a qualitative survey that will collect the experience of caregivers using the QPGE.

Read the detailed description

The use of isolation and mechanical restraint in psychiatry has deleterious consequences for the patient. Caregivers also testify to their dissatisfaction with using these methods. The Coping Agreement Questionnaire (CAQ) is a form presented to the patient admitted to a psychiatric unit in the United States that has shown a significant effect on the reduction of coercive measures. It has been translated into French under the name Questionnaire Préventif de la Gestion des Emotions (QPGE). In France, the Haute Autorité de Santé has been recommending this type of tool since 2016 in the form of shared prevention plans to better prevent moments of violence.

The main objective is to assess whether the use of a shared prevention plan based on the Preventive Emotions Management Questionnaire (QPGE) can reduce the rates of isolation measures and mechanical restraint in hospitalized people. in a sectoral admission unit receiving patients in care without consent.

Being tested
Questionnaire
Keywords
Psychiatric Disorder, Prevention, Mechanical restraint, Isolation
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    The study will compare the rates of isolation and restraint of the two sectoral admission units welcoming people in care without consent for a period of one year. The impact of the QPGE on the satisfaction scores will be systematically evaluated by a self-questionnaire for patients at the end of hospitalization. The QPGE is administered by a nurse during the reception interview of the patient in the unit.

Study groups in NCT05306717
Study groupRoleWhat they receive
EpidemiologyThe study will compare the rates of isolation and restraint of the two sectoral admission units welcoming people in care without consent for a period of one year.
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of isolation measures.(%)

    Isolation and/or restraint notified in the registers dedicated to the monitoring of measures restricting liberty in the admission units during the study period

    Measured: up to 1 year

  2. Rate of restraint measures.(%)

    Isolation and/or restraint notified in the registers dedicated to the monitoring of measures restricting liberty in the admission units during the study period

    Measured: up to 1 year

Secondary outcomes (5)
  1. Rate of isolation measures not associated with an episode of mechanical restraint (%)

    Measured: up to 1 year

  2. Duration of isolation measures not associated with an episode of mechanical restraint. (hours)

    Measured: up to 1 year

  3. Rate of mechanical restraint measures (%)

    Measured: up to 1 year

  4. Duration of mechanical restraint measures (hours)

    Measured: up to 1 year

  5. User satisfaction score at the end of hospitalization

    Measured: up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2022
  2. Study start1 Apr 2022
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
416 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05306717
Sponsor's protocol ID
2021-A03039-32
Acronym
PACT
Status last verified
Jun 2024
First submitted
14 Mar 2022
Last updated
18 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Beghi M, Peroni F, Gabola P, Rossetti A, Cornaggia CM. Prevalence and risk factors for the use of restraint in psychiatry: a systematic review. Riv Psichiatr. 2013 Jan-Feb;48(1):10-22. doi: 10.1708/1228.13611.

    PubMed 23438697
  • Riahi S, Thomson G, Duxbury J. An integrative review exploring decision-making factors influencing mental health nurses in the use of restraint. J Psychiatr Ment Health Nurs. 2016 Mar;23(2):116-28. doi: 10.1111/jpm.12285. Epub 2016 Jan 26.

    PubMed 26809740
  • Bowers L, Allan T, Simpson A, Nijman H, Warren J. Adverse incidents, patient flow and nursing workforce variables on acute psychiatric wards: the Tompkins Acute Ward Study. Int J Soc Psychiatry. 2007 Jan;53(1):75-84. doi: 10.1177/0020764007075011.

    PubMed 17333953
  • Bowers L, Alexander J, Bilgin H, Botha M, Dack C, James K, Jarrett M, Jeffery D, Nijman H, Owiti JA, Papadopoulos C, Ross J, Wright S, Stewart D. Safewards: the empirical basis of the model and a critical appraisal. J Psychiatr Ment Health Nurs. 2014 May;21(4):354-64. doi: 10.1111/jpm.12085. Epub 2014 Jan 24.

    PubMed 24460906

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatric Disorder, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of isolation measures.(%) (time frame: up to 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05306717, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in